EUCTR2006-001865-41-IT进行中（未招募）1 期
A phase III, Multicentre, Randomised, Double-Blind, Placebo controlled study to determine the efficacy and safety of lenalidomide (Revlimid in combination with Melphalan and Prednisone versus placebo plus melphalan and prednisone in subjects with newly diagnosed multiple myeloma who are 65 years of age or older - CC-5013-MM-015
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- Celgene
- 入组人数
- 450
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Able to understand and sign the ICF Aged at least 65 at time of ICF signature Newly diagnosed MM (according to three criteria)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Previous treatment with antimyeloma therapy Any severe medical condition while in the study Pregnant or breastfeeding mothers
研究者
相似试验
进行中（未招募）
1 期
A Trial to Assess the Safety and Efficacy of Emactuzumab versus Placebo in Patients with Giant Cell Tumours.Tenosynovial Giant Cell TumourMedDRA version: 21.1Level: LLTClassification code 10025564Term: Malignant giant cell tumorSystem Organ Class: 100000004864EUCTR2021-001716-29-ESSynOx Therapeutics Ltd160
进行中（未招募）
不适用
Evaluation of Ceftaroline Fosamil versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.EUCTR2011-004013-16-BGAstraZeneca AB825
进行中（未招募）
不适用
Evaluation of Ceftaroline Fosamil versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.complicated bacterial skin and soft tissue infectionsMedDRA version: 14.1Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-004013-16-ATAstraZeneca AB765
进行中（未招募）
不适用
Evaluation of Ceftaroline Fosamil versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections.Complicated bacterial skin and soft tissue infectionsMedDRA version: 14.1Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-004013-16-GRAstraZeneca AB765
进行中（未招募）
1 期
A Trial to Assess the Safety and Efficacy of Emactuzumab versus Placebo in Patients with Giant Cell Tumours.EUCTR2021-001716-29-ATSynOx Therapeutics Ltd160